Takeda Ruling On Expert Standards To Ripple Beyond Actos

By Sindhu Sundar (July 17, 2015, 8:27 PM EDT) -- A California appellate court's finding that a plaintiffs expert didn't have to rule out all other possible causes of a man's bladder cancer besides Takeda Pharmaceutical Co. Ltd. drug Actos will help plaintiffs combat companies' growing insistence on stricter standards for expert testimony, attorneys say....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!